Home › NCT06313359
Fall Risk and Quality of Life: in Individuals With Cancer Treatment Related Peripheral Neuropathy.
Fall Risk and Quality of Life: Influence of Dual Task Performance, Cognition, and Sensorimotor Variables in Individuals With Cancer Treatment Related Peripheral Neuropathy.
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: Experimental group * Individuals 18 years and older * diagnosed with non- CNS cancer who underwent treatment and presents with peripheral neuropathy symptoms. Control group * age (+/- one year) and gender matched individuals * no diagnosed peripheral neuropathy * No diagnosed cognitive symptoms. Exclusion Criteria: * Unable to follow two step commands. * Unable to ambulate x 50 feet independently without use of an assistive device. * Unable to use a phone to send text messages. * Diagnosis of diabetic peripheral neuropathy * Diagnosis of CNS cancer. * Unable to speak/understand English
About the study
The purpose of this research is to examine the impact of peripheral neuropathy on fall risk and quality of life in people who had cancer and neuropathy from cancer treatments. The investigators are interested to find out if the participant have any difficulty with thinking, feeling, balancing, or moving around that will contribute to risk for falls or quality of life. Investigators are also interested to see if the participants have any difficulty with doing two activities at the same time, such as walking and texting.
Sponsor: Texas Woman's University · Participants: 40 · Started: Mar 30, 2024
Contact the study team
- Priya Karakkattil · Phone: 12148625624
Official record on ClinicalTrials.gov — NCT06313359
Locations in the U.S.
| Texas | Texas Woman's University, Dallas |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.